Discrepancies in medication entries between anesthetic and pharmacy records using electronic databases.

Anesth Analg

Center for Informatics and Perioperative Management, Department of Anesthesiology, Perioperative Medicine and Pain Management, Miller School of Medicine, University of Miami, Miami, Florida 33136, USA.

Published: October 2007

Background: Accurate recording of disposition of controlled substances is required by regulatory agencies. Linking anesthesia information management systems (AIMS) with medication dispensing systems may facilitate automated reconciliation of medication discrepancies.

Methods: In this retrospective investigation at a large academic hospital, we reviewed 11,603 cases (spanning an 8-mo period) comparing records of medications (i.e., narcotics, benzodiazepines, ketamine, and thiopental) recorded as removed from our automated medication dispensing system with medications recorded as administered in our AIMS.

Results: In 15% of cases, we found discrepancies between dispensed versus administered medications. Discrepancies occurred in both the AIMS (8% cases) and the medication dispensing system (10% cases). Although there were many different types of user errors, nearly 75% of them resulted from either an error in the amount of drug waste documented in the medication dispensing system (35%); or an error in documenting the medication in the AIMS (40%).

Conclusions: A significant percentage of cases contained data entry errors in both the automated dispensing and AIMS. This error rate limits the current practicality of automating the necessary reconciliation. An electronic interface between an AIMS and a medication dispensing system could alert users of medication entry errors prior to finalizing a case, thus reducing the time (and cost) of reconciling discrepancies.

Download full-text PDF

Source
http://dx.doi.org/10.1213/01.ane.0000282021.74832.5eDOI Listing

Publication Analysis

Top Keywords

medication dispensing
20
dispensing system
16
medication
8
aims medication
8
entry errors
8
dispensing
6
aims
5
cases
5
discrepancies
4
discrepancies medication
4

Similar Publications

The Mark Cuban Cost Plus Drug Company Effect on Urogynecologic Drugs.

Urogynecology (Phila)

January 2025

From the Department of Urology, Atrium Health Wake Forest Baptist, Winston-Salem, NC.

Importance: The Mark Cuban Cost Plus Drug Company (ie, Cost Plus Drugs) is a service that makes generic drugs affordable. Cortese et al recently published the top 9 most commonly used oral medications in treatment of urologic conditions and showed that Cost Plus Drugs would have provided an estimated $1.29 billion reduction in 2020 costs if they replaced the Medicare prices.

View Article and Find Full Text PDF

Purpose: Oral corticosteroids (OCS) are recommended for the treatment of exacerbations in people with COPD; however, high cumulative lifetime doses (≥1000mg prednisolone-equivalent) are associated with adverse health effects. This issue is well defined in asthma but is less well understood in COPD. The aim of this study was to examine cumulative OCS dispensed to people with COPD over 12 months.

View Article and Find Full Text PDF

Purpose: The purpose of this study was to explore the lean management strategies used by an outpatient hospital pharmacy in China to reduce internal errors in prescription dispense and to describe their impact on patient satisfaction.

Methods: The type and number of internal errors in prescription dispense from January 1, 2022, to December 31, 2022, were collected. The causes of these errors were analyzed based on a series of lean management concepts and methods, and Lean Management was implemented from January 1, 2023, to December 31, 2023, in this outpatient hospital pharmacy.

View Article and Find Full Text PDF

Prescription Stimulant Dispensing to US Children: 2017-2023.

Pediatrics

January 2025

Susan B. Meister Child Health Evaluation and Research Center, Department of Pediatrics, University of Michigan Medical School, Ann Arbor, Michigan.

Objective: To evaluate changes in prescription stimulant dispensing to children aged 5 to 17 years associated with the COVID-19 pandemic and the shortage of immediate-release mixed amphetamine salts (Adderall), which was announced in October 2022.

Methods: We analyzed the 2017 to 2023 IQVIA Longitudinal Prescription Database, which captures 92% of US prescriptions. Using an interrupted time series design, we evaluated level and slope changes in the monthly stimulant-dispensing rate (number of children with stimulant dispensing per 100 000 children) in March 2020 and October 2022.

View Article and Find Full Text PDF

Disclaimer: In an effort to expedite the publication of articles, AJHP is posting manuscripts online as soon as possible after acceptance. Accepted manuscripts have been peer-reviewed and copyedited, but are posted online before technical formatting and author proofing. These manuscripts are not the final version of record and will be replaced with the final article (formatted per AJHP style and proofed by the authors) at a later time.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!